Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition (Tables)

6 Months Ended

Jun. 30, 2021

Deferred revenue consisted of the following:


	June 30, 2021		December 31, 2020
Deferred extended maintenance and support	$	2,568	$	2,902
Deferred royalties	280		282
Deferred device and advances	100		118
Total deferred revenues	2,948		3,302
Less current portion	(1,422)		(1,496)
Deferred revenues, non-current	$	1,526	$	1,806

Deferred revenue activity consisted of the following for the six months ended June 30, 2021:



Beginning balance	$	3,302
Deferral of revenue	548
Recognition of deferred revenue	(902)
Ending balance	$	2,948

The following table disaggregates the Company’s revenue by major source for the three months ended June 30, 2021:

The following table disaggregates the Company’s revenue by major source for the six months ended June 30, 2021:


	EksoHealth		EksoWorks		Total
Device revenue	$	2,109	$	386	$	2,495
Service and support	935		—		935
Subscriptions	337		122		459
Parts and other	194		24		218
Collaborative arrangements	14		—		14
	$	3,589	$	532	$	4,121

The following table disaggregates the Company’s revenue by major source for the three months ended June 30, 2020:


	EksoHealth		EksoWorks		Total
Device revenue	$	1,382	$	161	$	1,543
Service and support	333		—		333
Rentals and subscriptions	197		3		200
Parts and other	69		14		83
Collaborative arrangements	105		—		105
	$	2,086	$	178	$	2,264

The following table disaggregates the Company’s revenue by major source for the six months ended June 30, 2020:


	EksoHealth		EksoWorks		Total
Device revenue	$	1,688	$	416	$	2,104
Service and support	715		—		715
Rentals and subscriptions	478		3		481
Parts and other	223		36		259
Collaborative arrangements	172		—		172
	$	3,276	$	455	$	3,731